Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 5 clinical trials
Romosozumab/Denosumab Study for Premenopausal IOP

hypothesize that romosozumab will be associated with improvements in bone mass and microarchitecture in premenopausal women, and also that the responses and response rates will exceed those observed in

  • 0 views
  • 04 Apr, 2021
  • 2 locations
Study to Evaluate Romosozumab in Children and Adolescents With Osteogenesis Imperfecta

The primary objective of this study is to evaluate the pharmacokinetics (PK) profile following multiple subcutaneous (SC) doses of romosozumab in children and adolescents with Osteogenesis

  • 0 views
  • 26 Jun, 2021
  • 17 locations
Romosozumab in Women With Chronic SCI

This two-year open-label pilot clinical trial will evaluate the efficacy and safety of romosozumab to treat bone loss in females with chronic spinal cord injury (SCI) and osteoporosis (OP

  • 0 views
  • 15 Mar, 2021
  • 1 location
Romosozumab to Improve Bone Mineral Density and Architecture in Chronic SCI

Treatment for sublesional bone loss (osteoporosis) in persons with chronic, motor-complete spinal cord injury (SCI) has been limited and unsuccessful to date. Romosozumab, a sclerostin

  • 0 views
  • 30 Apr, 2021
  • 2 locations
Bone-biomarkers of Spinal Cord Injury Patients

, romosozumab, a sclerostin inhibitor, has been reported to have a high therapeutic effect as an inhibitor of bone resorption while promoting bone formation. However, there are a few research concerning

spinal cord injury
spinal cord disorder
spinal cord
injuries
osteoporosis
  • 20 views
  • 25 Jan, 2021
  • 1 location